The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
KYMERA THERAPEUTICS INC COM 501575104 36,178 615,895 SH   DFND 1 615,895 0 0
VELO3D INC COMMON STOCK 92259N104 285,231 37,864,240 SH   DFND 1 37,864,240 0 0
BRIGHT HEALTH GROUP INC COM 10920V107 474,767 64,646,937 SH   DFND 1 64,646,937 0 0
OTONOMO TECHNOLOGIES LTD ORDINARY SHARES M7571L103 83,762 19,470,539 SH   DFND 1 19,470,539 0 0
SPIRE GLOBAL INC. COM CL A 848560108 82,073 7,277,945 SH   DFND 1 7,277,945 0 0
TSCAN THERAPEUTICS INC COM 89854M101 9,349 1,245,505 SH   DFND 1 1,245,505 0 0